Jason, Leonard A, Corradi, Karina, Torres-Harding, Susan et al. · Neuropsychology review · 2005 · DOI
ME/CFS is a complex condition that affects people in different ways, and researchers found that treating it as one single disease may not be helpful. This review shows that patients with ME/CFS have different combinations of symptoms, different levels of disability, and different biological markers (measurable signs in the body), suggesting the condition should be divided into subtypes. Just like how different patients with diabetes or heart disease need different treatment approaches, ME/CFS patients might benefit from being grouped into categories so doctors can provide more targeted care.
This work is crucial because it challenges the one-size-fits-all approach to ME/CFS diagnosis and highlights the need for precision medicine. Recognizing ME/CFS subtypes could help researchers design better treatment trials by enrolling more homogeneous patient groups, potentially explaining why many treatments have shown mixed results. For patients, subtype classification could eventually lead to personalized treatment plans tailored to their specific biological and symptom profiles rather than generic management approaches.
This review does not establish which specific subtypes exist or provide validated biomarker criteria for dividing patients into groups. It does not prove that subtyping will actually improve patient outcomes or treatment efficacy—only that it is theoretically justified and warrants further investigation. The paper identifies the need for subtypes based on observed heterogeneity but does not present primary empirical data validating any particular subtyping scheme.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.